Last reviewed · How we verify

GCFLU Quadrivalent Inj. vaccine

Green Cross Corporation · Phase 3 active Biologic

GCFLU Quadrivalent Inj. vaccine is a Inactivated influenza vaccine Biologic drug developed by Green Cross Corporation. It is currently in Phase 3 development for Seasonal influenza prevention in adults and children. Also known as: GCFLU Quadrivalent Inj..

GCFLU Quadrivalent is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against four strains of influenza virus.

GCFLU Quadrivalent is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against four strains of influenza virus. Used for Seasonal influenza prevention in adults and children.

At a glance

Generic nameGCFLU Quadrivalent Inj. vaccine
Also known asGCFLU Quadrivalent Inj.
SponsorGreen Cross Corporation
Drug classInactivated influenza vaccine
ModalityBiologic
Therapeutic areaImmunology / Infectious Disease
PhasePhase 3

Mechanism of action

The vaccine contains inactivated (killed) virus particles or viral antigens from four influenza strains (typically two A subtypes and two B lineages). Upon injection, these antigens trigger both humoral and cellular immune responses, leading to the production of strain-specific antibodies and memory B cells that provide protection against infection with matching circulating influenza viruses.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about GCFLU Quadrivalent Inj. vaccine

What is GCFLU Quadrivalent Inj. vaccine?

GCFLU Quadrivalent Inj. vaccine is a Inactivated influenza vaccine drug developed by Green Cross Corporation, indicated for Seasonal influenza prevention in adults and children.

How does GCFLU Quadrivalent Inj. vaccine work?

GCFLU Quadrivalent is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against four strains of influenza virus.

What is GCFLU Quadrivalent Inj. vaccine used for?

GCFLU Quadrivalent Inj. vaccine is indicated for Seasonal influenza prevention in adults and children.

Who makes GCFLU Quadrivalent Inj. vaccine?

GCFLU Quadrivalent Inj. vaccine is developed by Green Cross Corporation (see full Green Cross Corporation pipeline at /company/green-cross-corporation).

Is GCFLU Quadrivalent Inj. vaccine also known as anything else?

GCFLU Quadrivalent Inj. vaccine is also known as GCFLU Quadrivalent Inj..

What drug class is GCFLU Quadrivalent Inj. vaccine in?

GCFLU Quadrivalent Inj. vaccine belongs to the Inactivated influenza vaccine class. See all Inactivated influenza vaccine drugs at /class/inactivated-influenza-vaccine.

What development phase is GCFLU Quadrivalent Inj. vaccine in?

GCFLU Quadrivalent Inj. vaccine is in Phase 3.

What are the side effects of GCFLU Quadrivalent Inj. vaccine?

Common side effects of GCFLU Quadrivalent Inj. vaccine include Injection site pain, redness, or swelling, Myalgia (muscle pain), Headache, Fatigue, Low-grade fever.

Related